# Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder

> **NCT03430180** · PHASE2 · UNKNOWN · sponsor: **Finnish Institute for Health and Welfare** · enrollment: 126 (estimated)

## Conditions studied

- Pathological Gambling
- Gambling Disorder
- Opioid Antagonist
- Naloxone

## Interventions

- **DRUG:** Naloxone hydrochloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03430180
- **Lead sponsor:** Finnish Institute for Health and Welfare
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-22
- **Primary completion:** 2019-08-30
- **Final completion:** 2020-03-30
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2019-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03430180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03430180, "Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03430180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*